In a diabetic patient on dapagliflozin who has been underhydrated for 2 days and now presents with fever, chills, and dysuria, what is the recommended treatment?

Immediate Treatment: Stop Dapagliflozin and Treat the UTI

This patient requires immediate discontinuation of dapagliflozin, aggressive fluid rehydration, and prompt antibiotic therapy for a urinary tract infection (UTI). The combination of dehydration, fever, and dysuria in a patient on an SGLT2 inhibitor creates a high-risk scenario for serious complications including urosepsis, pyelonephritis, and diabetic ketoacidosis 1.

Critical First Steps

1. Discontinue Dapagliflozin Immediately

• The FDA label explicitly warns to withhold dapagliflozin in clinical situations predisposing to volume depletion 1
• SGLT2 inhibitors significantly increase UTI risk, particularly serious infections like urosepsis and pyelonephritis requiring hospitalization 1
• The 2023 sick day medication guidance consensus strongly recommends temporarily stopping SGLT2 inhibitors during acute illness with volume depletion 2

2. Assess Severity and Triage

Check immediately for severe warning signs that require emergency care 2:

• Reduced consciousness or new confusion
• Blood pressure (systolic <80 mmHg or drop of 20 mmHg)
• Heart rate increase (>30 bpm above baseline)
• Inability to keep fluids down
• Check ketones (blood or urine) - critical given SGLT2 inhibitor use

3. Aggressive Fluid Rehydration

• Start immediate oral rehydration with electrolyte-containing fluids 2
• If unable to tolerate oral fluids or showing signs of severe dehydration, IV fluids are required
• The FDA specifically warns that dapagliflozin causes intravascular volume depletion, with post-marketing reports of acute kidney injury requiring dialysis 1

4. Antibiotic Therapy for UTI

• Start empiric broad-spectrum antibiotics immediately for suspected pyelonephritis (given fever and systemic symptoms) 1
• Common regimens: fluoroquinolone (ciprofloxacin) or third-generation cephalosporin
• Obtain urine culture before starting antibiotics if possible, but do not delay treatment
• Research confirms dapagliflozin increases UTI risk, with higher rates at 10mg dose and longer treatment duration 3, 4

Monitoring Requirements

During the acute illness (next 24-72 hours):

• Monitor blood glucose every 4-6 hours - expect glucose to rise after stopping dapagliflozin 2
• Check ketones if glucose >250 mg/dL or patient has nausea/vomiting 2, 1
• Monitor renal function (creatinine/eGFR) - SGLT2 inhibitors can cause acute kidney injury when combined with dehydration 1
• Assess volume status and vital signs regularly
• Monitor for resolution of fever and urinary symptoms

Diabetes Management During Acute Illness

Temporary glucose control while dapagliflozin is held:

• If glucose rises significantly, use short-acting insulin for correction
• Do NOT restart dapagliflozin until patient is clinically stable, afebrile, eating/drinking normally, and UTI is resolving 1
• The sick day guidance recommends waiting until symptoms resolve or maximum 72 hours before reassessing 2

Critical Pitfalls to Avoid

1. Do not continue dapagliflozin during acute illness - this is the most common and dangerous error. The drug increases glucosuria, which worsens UTI risk and promotes bacterial growth 5, 6

2. Do not miss diabetic ketoacidosis - SGLT2 inhibitors can cause euglycemic DKA (ketoacidosis with normal glucose levels), making diagnosis difficult 1, 7. Check ketones regardless of glucose level if patient has nausea, vomiting, or abdominal pain.

3. Do not underestimate UTI severity - the FDA specifically warns about urosepsis and pyelonephritis requiring hospitalization in SGLT2 inhibitor users 1. Fever with dysuria suggests upper tract involvement.

4. Do not restart dapagliflozin too early - wait until patient is fully rehydrated, afebrile for 24-48 hours, completing antibiotic course, and able to maintain adequate oral intake 2, 1

When to Seek Emergency Care

Send to emergency department immediately if:

• Reduced consciousness or confusion
• Cannot keep fluids down
• Systolic BP <80 mmHg
• Moderate or high ketones detected
• Rapid or difficult breathing
• Persistent fever >38°C despite initial treatment 2

Long-term Considerations

After this episode resolves, consider whether dapagliflozin is the best SGLT2 inhibitor choice for this patient. Research shows dose-dependent UTI risk, with 10mg dapagliflozin showing higher infection rates than 5mg 3, 4. Alternative diabetes medications or lower doses may be appropriate for patients with recurrent UTIs. The patient must be educated about adequate hydration (especially in summer) and sick day management before restarting 2, 8.